SYNTHESIS OF MACROCYCLES STEROIDS CYCLOPENTANOIDS ETC
大环类固醇环戊烷等的合成
基本信息
- 批准号:6180035
- 负责人:
- 金额:$ 43.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-06-01 至 2002-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: Exploring biological phenomena at a molecular level provides
the basis of understanding from which new therapeutic agents derive. The
ability to construct a defined molecular architecture requires highly
selective reactions and reagents to permit the development of effective
synthetic strategies. Cyclic compounds have biological activities across a
broad spectrum. Furthermore, constraining conformations of mobile molecules
by forming rings also frequently enhances biological potency. Thus, a
concerted effort to apply new chemical principles being developed in the
PI's laboratories to the formation of rings becomes an important objective.
In the first phase, a new concept to create macrocycles (rings larger than
seven members) may provide a unique opportunity to approach a variety of
significant targets. Some examples include the antiinflammatory nine
membered macrolides ascidiatrienolides, the antitumor eight membered
carbocycles, the shikoccins, and the azocines, FR-99048 and FR-66979, the
ten membered macrolactam neuropeptidase inhibitor CGS-25155,the fourteen
membered antiviral and antifungal fluviricinines, and the nineteen membered
serine protease inhibitors, the cyclotheonamides. In the second phase, a
new reactivity mode for shuffling protons in totally unconventional methods
offers novel approaches to cyclizations. Vitamin D analogues and
derivatives represent a most important direction for creation of clinically
important therapeutic agents. A new concept for their synthesis based upon
novel strategies for asymmetric induction will be pursued. A variation on
this methodology may extend the reaction to a facile asymmetric synthesis of
either cis or trans fused drimanes and related classes of terpenoids from a
common intermediate, a class of compounds that have remarkably broad
biological activities including antibacterial, antifungal, antimalarial,
antiinflammatory, cytotoxic, and insecticidal. A new class of reactions
provides a novel atom economical approach for formation of heterocycles.
This invention stimulates exploration of a potentially, greatly simplified
strategy to the important food toxin, aflatoxin. The envisioned asymmetric
route also may provide a simple protocol for the asymmetric synthesis of
physostigmines, one of whose members is a candidate for treatment of
myasthenia gravis, glaucoma, and Alzheimer's disease.
A third phase examines a new class of cycloaddition reactions to create odd
membered rings. Exploring a new class of acceptors in conjunction with a
novel class of reactive intermediates creates a conceptual framework to the
anthelmintic and antinematodal mold metabolites paraherquamide and
marcfortine. An unusual (6+3) cycloaddition may create strategies for the
structurally unusual farnesyl transferase inhibitor CP-263,114 and simpler
analogues. Ring expansion methods may convert these cores into the taxoid
skeleton with appropriate functionality at key points for analog
development.
描述:在分子水平上探索生物现象提供
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARRY M TROST其他文献
BARRY M TROST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARRY M TROST', 18)}}的其他基金
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS:
抗肿瘤化合物的新合成方法:
- 批准号:
7724151 - 财政年份:2008
- 资助金额:
$ 43.29万 - 项目类别:
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS
大环内酯类、类固醇类、环戊类化合物等合成设计
- 批准号:
7724152 - 财政年份:2008
- 资助金额:
$ 43.29万 - 项目类别:
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS
大环内酯类、类固醇类、环戊类化合物等合成设计
- 批准号:
7601802 - 财政年份:2007
- 资助金额:
$ 43.29万 - 项目类别:
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRALS, HIV
抗肿瘤化合物的新合成方法:抗病毒药物、HIV
- 批准号:
7601801 - 财政年份:2007
- 资助金额:
$ 43.29万 - 项目类别:
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS
大环内酯类、类固醇类、环戊类化合物等合成设计
- 批准号:
7369021 - 财政年份:2006
- 资助金额:
$ 43.29万 - 项目类别:
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRAL AGENTS, HIV
抗肿瘤化合物的新合成方法:抗病毒药物、HIV
- 批准号:
7369020 - 财政年份:2006
- 资助金额:
$ 43.29万 - 项目类别:
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS
大环内酯类、类固醇类、环戊类化合物等合成设计
- 批准号:
7180903 - 财政年份:2005
- 资助金额:
$ 43.29万 - 项目类别:
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRAL AGENTS, HIV
抗肿瘤化合物的新合成方法:抗病毒药物、HIV
- 批准号:
7180902 - 财政年份:2005
- 资助金额:
$ 43.29万 - 项目类别:
NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRAL AGENTS, HIV
抗肿瘤化合物的新合成方法:抗病毒药物、HIV
- 批准号:
6976589 - 财政年份:2004
- 资助金额:
$ 43.29万 - 项目类别:
MACROLIDES, STEROIDS, CYCLOPENTANOIDS, ETC SYNTHETIC DESIGNS
大环内酯类、类固醇类、环戊类化合物等合成设计
- 批准号:
6976590 - 财政年份:2004
- 资助金额:
$ 43.29万 - 项目类别:
相似海外基金
Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance
通过创新治疗方案最大限度地减少耐药性,延长抗真菌药物的效用和持久性
- 批准号:
MR/Y002164/1 - 财政年份:2024
- 资助金额:
$ 43.29万 - 项目类别:
Research Grant
Engineering microbial cell factories for production of improved polyene antifungal agents
工程微生物细胞工厂用于生产改进的多烯抗真菌剂
- 批准号:
2898887 - 财政年份:2023
- 资助金额:
$ 43.29万 - 项目类别:
Studentship
Morphological profiling for the development of antifungal agents
用于开发抗真菌药物的形态分析
- 批准号:
22H02216 - 财政年份:2022
- 资助金额:
$ 43.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
An efficient approach to find therapeutically effective antifungal agents
寻找治疗有效的抗真菌药物的有效方法
- 批准号:
22K05337 - 财政年份:2022
- 资助金额:
$ 43.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating light-activated therapeutic compounds as antifungal agents.
研究光激活治疗化合物作为抗真菌剂。
- 批准号:
2753345 - 财政年份:2022
- 资助金额:
$ 43.29万 - 项目类别:
Studentship
Discovery of novel therapeutic agents for biliary tract and pancreatic cancer based on antifungal agents
基于抗真菌药物的胆道癌和胰腺癌新型治疗药物的发现
- 批准号:
20H03533 - 财政年份:2020
- 资助金额:
$ 43.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of antifungal agents that target essential protein kinases in A. fumigatus.
开发针对烟曲霉必需蛋白激酶的抗真菌剂。
- 批准号:
2456629 - 财政年份:2020
- 资助金额:
$ 43.29万 - 项目类别:
Studentship
Elucidation of tip growth factor of fungi and construction of screeing system for antifungal agents
真菌尖端生长因子的阐明及抗真菌药物筛选体系的构建
- 批准号:
19K05738 - 财政年份:2019
- 资助金额:
$ 43.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Ambruticins: An inspiration to develop novel biocatalysts and antifungal agents
Ambruticins:开发新型生物催化剂和抗真菌剂的灵感
- 批准号:
2107517 - 财政年份:2018
- 资助金额:
$ 43.29万 - 项目类别:
Studentship